ViAqua

Rehovot, Israel Founded: 2014 • Age: 12 yrs
RNAi drug delivery technology is developed for aquaculture disease prevention.

About ViAqua

ViAqua is a Technology company based in Rehovot (Israel) founded in 2014 by Shai Ufaz and Shai Einbinder. RNAi drug delivery technology is developed for aquaculture disease prevention. It operates in the Technology and Agriculture sectors. ViAqua has raised $12.55 million across 5 funding rounds from investors including Nutreco, The Trendlines Group and Thai Union Group. Its chief executive, as recorded, is Shai Ufaz. ViAqua offers products and services including RNAi Delivery Platform. Its focus areas include High Tech, Nanotechnology, Nanoenabled Products and Life Science. Its legal entity is ViAqua Therapeutics Ltd.

Company details

ViAqua was founded in 2014 in Rehovot, Israel, focusing on the aquaculture sector. RNAi nanoparticle formulations are developed as a drug delivery platform for oral or immersion administration. Treatments are designed to halt disease progression and prevent viral outbreaks in aquatic species. Cellular responses are triggered by the technology to neutralize infections, with delivery occurring through feed integration or direct immersion methods.

  • Headquarters Rehovot, Israel
  • Founders Shai Ufaz, Shai Einbinder
  • Sectors
    Technology
    Agriculture
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website viaqua-t.com
  • Social LinkedIn
  • Legal Name Viaqua Therapeutics Ltd
Key Metrics
  • Total Equity Funding
    $12.55M (USD)

    in 5 rounds

  • Latest Funding Round
    $8.25M (USD), Series A

    Sep 2023

  • Investors
    Nutreco

    & 8 more

Products & Services of ViAqua

ViAqua offers a comprehensive portfolio of products and services, including RNAi Delivery Platform.

RNAi Delivery Platform
Aquaculture Health

Encapsulated RNA in feed for preventing viral diseases in shrimp.

Funding Insights of ViAqua

ViAqua has successfully raised a total of $12.55M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $8.25 million completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $12.55M
  • Total Rounds 5
  • Last Round Series A β€” $8.25M
  • Investors Count 9

All 5 funding rounds of ViAqua with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2023$8.25MSeries A–S2G Ventures
Jun 2021$4.3MSeries A–S2G Ventures
Dec 2018Series A––
Jul 2018Series A–Nutreco
–
Sep 2016Seed––
Valuation history

9 investors in total: 9 institutional.

Investors in ViAqua

ViAqua has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Nutreco, The Trendlines Group and Thai Union Group.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Stage agnostic venture capital firm
s2gventures.comChicago, United States
raboventures.com
Venture capital fund and startup incubator for healthcare and agricultural companies
1993trendlines.comMisgav, Israel
Venture capital is deployed into agrifood tech startups.
2014claycapital.vcLondon, United Kingdom
Provider of animal nutrition solutions and technologies
1994nutreco.comAmersfoort, Netherlands
Seafood products are distributed globally by Thai Union Group.
1977thaiunion.comBangkok, Thailand
Hosts a digital marketplace for farm machinery and parts.
2021agriline.netPoland
Multiple engineering courses and degrees are offered by Technion college.
1912technion.ac.ilHaifa, Israel
Business development in Israel is supported by a government organization.
1965matimop.org.ilJerusalem, Israel
Premium access

Investor details for ViAqua

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of ViAqua

8 people are tracked at ViAqua (3 in leadership, 1 in board & advisors, 4 in team).

NameRoleGroup
Shai Ufaz
Co-Founder & CEOLeadership
Shai Einbinder
Co-FounderLeadership
Chris Beattie
Active DirectorLeadership
Avi Schroeder
Scientific AdvisorBoard & advisors
Ami Schlesinger
EVP, Business DevelopmentTeam
Adi Saadya
BiologistTeam
Doron Levy
Research And Development Project ManagerTeam
Svetlana Fridman
Research and Development Project ManagerTeam
Premium access

Complete people profiles for ViAqua

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of ViAqua

3 dated milestones of ViAqua across 9 years, from founding to its latest funding, stage changes and deals.

  1. Founded ViAqua is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Series A, of $8.2M.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Viaqua

Premium access

Complete news archive for ViAqua

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about ViAqua

ViAqua was founded in 2014 and raised its 1st funding round 2 years after it was founded.

ViAqua is headquartered in Rehovot, Israel. It is registered at Rehovot, Central District, Israel.

Shai Ufaz is the CEO of ViAqua, as recorded in our data. They have also founded this company.

ViAqua is a funded company, having raised a total of $12.55M across 5 funding rounds to date.

ViAqua was founded in 2014 in Rehovot, Israel, focusing on the aquaculture sector. RNAi nanoparticle formulations are developed as a drug delivery platform for oral or immersion administration. Treatments are designed to halt disease progression and prevent viral outbreaks in aquatic species. Cellular responses are triggered by the technology to neutralize infections, with delivery occurring through feed integration or direct immersion methods.

ViAqua offers RNAi Delivery Platform.

ViAqua operates through Viaqua Therapeutics Ltd.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available